Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Indivior Investors Sue Over Opioid Treatment Marketing Probe

April 24, 2019, 2:42 PM

Indivior PLC was hit with a lawsuit April 23 alleging it misled investors about marketing tactics for opioid addiction treatment drug Suboxone Film, which led to an indictment.

The company withheld information from investors about its “illicit nationwide scheme” to get doctors to increase Suboxone prescriptions, the complaint filed in the U.S. District Court for the District of New Jersey said. The U.S. Justice Department indicted Indivior April 9 for allegedly deceiving doctors about the drug’s susceptibility to abuse.

Suboxone is intended as a harder-to-abuse opioid that can help patients suffering from opioid addiction avoid painful withdrawals. But Indivior sought ...